Compound F779-0434 causes synthetic lethality in BRCA2-deficient cancer cells by disrupting RAD52–ssDNA association
Open Access
- 23 May 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (34) , 18859-18869
Abstract
Maintenance of genomic integrity is essential for the survival of all organisms. Homologous recombination (HR) is the major pathway for high-fidelity repair of DNA double-stranded breaks (DSBs). In addition to the classic BRCA–RAD51 pathway, another secondary HR sub-pathway dependent on RAD52 has been suggested to be functioning in mammalian cells. Importantly, RAD52 has been shown to be synthetically lethal to BRCA1/2-deficient cells, rendering RAD52 to be a desirable target in cancer therapy. In the current study, we performed a structure-based virtual screening of 47 737 drug-like compounds to identify RAD52-specific inhibitors. The top ranked virtual screening hits were further characterized using molecular dynamics simulation and biochemical and cell-based assays. We found that one compound, namely, F779-0434 specifically suppressed the growth of BRCA2-deficient cells and disrupted RAD52–ssDNA interaction in vitro. This RAD52-specific inhibitor identified in the current study is a promising compound for targeted cancer therapy, and it can also be used as a probe to study the mechanisms of DNA repair in human cells.Keywords
Funding Information
- Ministry of Human Resources and Social Security
- National Natural Science Foundation of China (31500657)
- Science and Technology Department of Sichuan Province (2017HH0097)
This publication has 59 references indexed in Scilit:
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- Rad52 inactivation is synthetically lethal with BRCA2 deficiencyProceedings of the National Academy of Sciences, 2010
- PARP inhibition: PARP1 and beyondNature Reviews Cancer, 2010
- Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesisNature Reviews Molecular Cell Biology, 2010
- Homologous recombination in DNA repair and DNA damage toleranceCell Research, 2008
- Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approachChemico-Biological Interactions, 2008
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- The Concept of Synthetic Lethality in the Context of Anticancer TherapyNature Reviews Cancer, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003